Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioNxt Solutions Inc C.BNXT

Alternate Symbol(s):  BNXTF

Healthcare
BioNxt Solutions Inc. is a bioscience company. The Company is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active... see more

Recent & Breaking News (CSE:BNXT)

Infectious Disease Oral Biosensor Function Confirmed

Accesswire June 29, 2020

XPhyto Therapeutics Corp.: Infectious Disease Oral Screening Test Advancement

Newsfile June 15, 2020

XPhyto's Diagnostic Partners Receive BMBF Grant for Infectious Disease Screening Tests

Newsfile June 10, 2020

Parkinson's Generic Transdermal Drug Delivery System

Accesswire June 8, 2020

Oettinger Brewery Signs Exclusive Agreement with Xphyto for Cannabis-Infused Beverages

Accesswire May 12, 2020

Infectious Disease Oral Dissolvable Biosensor Development

Accesswire April 22, 2020

Why XPhyto is OUTPERFORMING EVERYONE

Marc Davis April 21, 2020

Covid-19 Screening Test, Oral Thin Film Biosensor Products and High-Throughput Biosensor Identification Platform

Accesswire April 20, 2020

Exclusive Advisory Agreement Signed for COVID-19 and Host Cell Interactions

Accesswire March 25, 2020

RETRANSMISSION: COVID-19 Test and Development Programs Update

Newsfile March 23, 2020

XPhyto Announces COVID-19 Test and Development Programs Update

Newsfile March 20, 2020

XPhyto Therapeutics Epilepsy Treatment Program

Accesswire March 18, 2020

XPhyto Therapeutics Initiates Infectious Disease Programs

Newsfile March 3, 2020

Exclusive Strategic Partnership Commenced Between XPhyto Therapeutics and Elite Bavarian Brewing & Beverage Institute Weihenstephan

Newsfile February 18, 2020

XPhyto Therapeutics Announces Strategic Supply, Import and Distribution Agreement for the German Cannabis Market

Newsfile January 27, 2020

PharmaCielo Announces 30,000 Kg Cannabis Extract Agreement for German Market

Canada NewsWire January 27, 2020

Epilepsy Treatment to Be Developed with XPhyto Therapeutics' Oral Thin Film Delivery System

Newsfile December 9, 2019

XPhyto Therapeutics Pharmaceutical-Grade Cannabis Extraction Lab

Newsfile November 25, 2019

Xphyto Therapeutics Oral and Transdermal Cannabis Delivery and Dosage Systems

Newsfile November 12, 2019

XPhyto Therapeutics to Present at Munich Investment Conference 08 and 09 November 2019

Accesswire November 5, 2019